Prostate Cancer Clinical Trials
There are 65 registered clinical trials for Prostate Cancer in the TrialLens index.
Trials (65)
- Selecting Hypoxic Tumours for Treatment Modification N/A · University of Manchester
- TH1902 in Patients With Advanced Solid Tumors Phase 1 · Theratechnologies
- Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer N/A · Lightpoint Medical Limited
- PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition N/A · Ontario Cancer Research Network
- Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer Phase 2 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis N/A · Shanghai Changzheng Hospital
- Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC) Phase 2 · M.D. Anderson Cancer Center
- A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy Phase 1/2 · Cellbion Co., Ltd.
- Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer Phase 1 · C Ray Therapeutics
- The Efficacy of Pilates in the Recovery of Post-prostatectomy Urinary Incontinence N/A · Universidade Estadual de Londrina
- MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer N/A · University of Miami
- Focal Salvage Brachytherapy Study (FocaSaBra) N/A · The Greater Poland Cancer Centre
- Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial) Phase 2 · Latin American Cooperative Oncology Group
- Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer Phase 3 · Sanofi
- Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer N/A · OHSU Knight Cancer Institute
- Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer. N/A · EDAP TMS S.A.
- DNA Changes in Patients With Prostate Cancer N/A · ECOG-ACRIN Cancer Research Group
- 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer Phase 3 · Clarity Pharmaceuticals Ltd
- Male Stress Urinary Incontinence and Sexual Health N/A · Stanford University
- Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection N/A · Chinese University of Hong Kong
- The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer N/A · National Taiwan University Hospital
- A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer Phase 1 · Biotech Equity Partners Pty Ltd
- The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide Phase 4 · Yonsei University
- Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer Phase 3 · Sven Löffeler
- PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer. Phase 3 · M.D. Anderson Cancer Center
- Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data N/A · Brigham and Women's Hospital
- Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate Biopsy N/A · Post Graduate Institute of Medical Education and Research, Chandigarh
- Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study) Phase 4 · Deventer Ziekenhuis
- Hormone Therapy in Treating Patients With Advanced Prostate Cancer Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC
- Partnership for Healthy Seniors N/A · Johns Hopkins Bloomberg School of Public Health
- Effect of Beta-alanine and Pelvic Floor Muscle Training on Urinary Incontinence After Radical Prostatectomy (BELA) N/A · University Hospital Olomouc
- STHLM3 - Prostate Cancer Diagnostic Trial N/A · Karolinska Institutet
- Open-Label, Randomised Parallel-Group Study Phase 3 · Ferring Pharmaceuticals
- Prostate Cancer E-Health-Tutorial N/A · Zurich University of Applied Sciences
- Hypofractionated Radiotherapy for Prostate Cancer N/A · Consorci Sanitari de Terrassa
- Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases Phase 2 · M.D. Anderson Cancer Center
- Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer Phase 2 · Burzynski Research Institute
- Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy. Phase 2 · Novartis Pharmaceuticals
- Markers for Early Detection of Prostate Cancer N/A · National Cancer Institute (NCI)
- Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications N/A · Novosanis NV
- Active Control of Prostatic Cancer With Criteria of Latence N/A · Clinique Mutualiste Chirurgicale de la Loire
- A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer Phase 1 · Stanford University
- Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy Phase 3 · Haruhiko Fukuda
- Postoperative Prognosis Management Service Based mHealth for Prostate Cancer Patients N/A · Seoul St. Mary's Hospital
- Predicting Cognitive Decline From Androgen Deprivation Therapy N/A · University of California, San Francisco
- Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients Phase 1 · Sensei Biotherapeutics, Inc.
- STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer N/A · Karolinska Institutet
- Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer N/A · Dana-Farber Cancer Institute
- Hypofractionated Radiotherapy With Magnetic Resonance Imaging-Guided Focal Boost and Pelvic Irradiation in High-Risk Prostate Cancer Phase 2 · Haukeland University Hospital
- Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC
Related landscapes
- Phase 4 Prostate Cancer
- Phase 1/2 Prostate Cancer
- Phase 2 Prostate Cancer
- Phase 3 Prostate Cancer
- N/A Prostate Cancer
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.